07:26 AM EDT, 05/10/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) reported Q1 earnings Friday of $1.21 per diluted share, up from $1.17 a year earlier.

Analysts polled by Capital IQ expected $1.00.

Net revenue for the quarter ended March 31 was $137.4 million, up from 106.8 million a year earlier.

Analysts surveyed by Capital IQ expected $126 million.

The company expects full-year 2024 diluted earnings of $4.26 to $4.67. Analysts surveyed by Capital IQ expect $4.48. The company expects revenue for the year of $520 million to $542 million. Analysts polled by Capital IQ expect $535.11 million.